Insider · CIK 0001708748
Russell D Gannaway
Files at REFLX (PIMCO Flexible Real Estate Income Fund). First filing Jan 10, 2025, latest Jan 10, 2025.
In brief
Russell D Gannaway files SEC Form 4 as insider at REFLX (PIMCO Flexible Real Estate Income Fund). Since Jan 10, 2025, Russell D Gannaway has reported 1 open-market buy worth $1.0M and 0 open-market sells worth $0, the latest filed on Jan 10, 2025.
A track record needs three past buys with six months of prices behind them; Russell D Gannaway has 0, so none is measured yet.
The newest scored trade: bought $1.0M of REFLX on Jan 7, 2025, filed Jan 10, 2025, scored 39 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 39Weak | REFLXbuy PIMCO Flexible Real Estate Income Fund | $1.0M 95,511 shares | +30% | - |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 7, 2025 | REFLX PIMCO Flexible Real Estate Income Fund | POpen-market purchase COMMON SHARES | +95,511 | $10.47 | $1.0M | 414,167 | Jan 10, 2025 |
Questions about Russell D Gannaway
Answered from the filings on this page, as of the latest one.
Is Russell D Gannaway buying or selling?
Not in the last 12 months. Russell D Gannaway's latest open-market trade on SEC Form 4 was bought $1.0M of REFLX on Jan 7, 2025.
How did Russell D Gannaway's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Russell D Gannaway has 0.
Where does Russell D Gannaway file Form 4?
Russell D Gannaway has filed Form 4 at REFLX (PIMCO Flexible Real Estate Income Fund). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.